Gujarat Cotex Ltd files financial results for quarter ended 30 June 2026
The company submitted its quarterly financial statements for the period ended 30 June 2026, filed on 21 July 2026 with BSE.
What Gujarat Cotex Ltd announced
Gujarat Cotex Ltd submitted its financial results for the period ended 30 June 2026. The filing was made on 21 July 2026 at 12:20:30 UTC and is available on the BSE portal as a PDF document. No specific financial numbers (revenue, profit, EPS, etc.) are quoted in the brief announcement.
Filing details
- Company: Gujarat Cotex Ltd
- BSE Scrip Code: 514386 (no NSE ticker disclosed)
- Period covered: 1 April 2026 – 30 June 2026 (quarterly reporting)
- Filing date & time: 21 July 2026, 12:20:30 UTC
- Document: "Submission of Financial Results for Period ended 30th June, 2026" (PDF)
The PDF linked in the filing contains the complete set of financial statements, including the balance sheet, profit & loss account, cash‑flow statement and accompanying notes.
Key facts at a glance
| Detail | Value |
|---|---|
| Company | Gujarat Cotex Ltd |
| BSE ticker | 514386 |
| Reporting period | 30 June 2026 (quarter) |
| Filing date | 21 July 2026 |
| Document type | Quarterly financial results (PDF) |
| Source | BSE (https://www.bseindia.com/…) |
Why this matters for investors
The filing confirms that Gujarat Cotex Ltd has complied with its statutory reporting obligations for the quarter ending 30 June 2026. While the announcement itself does not reveal performance metrics, the underlying PDF will provide investors with insight into revenue trends, profitability, cash‑flow health and any material changes in the balance sheet. Access to the full statements is essential for assessing the company’s short‑term financial health and for comparing against prior periods.
Conclusion
Gujarat Cotex Ltd has officially lodged its Q1 FY2026 results with the BSE on 21 July 2026. Detailed financial figures are contained in the attached PDF, and investors should review that document to evaluate the company’s performance for the quarter. No further regulatory approvals are indicated in the filing.
Frequently asked questions
Related stocks
Source filing: view original